콘텐츠로 건너뛰기
Merck

1.20091

Parteck® SLC 500

EMPROVE® ESSENTIAL, Ph. Eur., NF

동의어(들):

Silica, colloidal anhydrous silica, colloidal silica, colloidal silicon dioxide, fumed silica, fumed silicon dioxide, highly disperse silicon dioxide, light anhydrous silicic acid, silica, Silicon dioxide

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

제품정보 (DICE 배송 시 비용 별도)

Linear Formula:
SiO2
CAS 번호:
7631-86-9
Molecular Weight:
60.08
UNSPSC Code:
12352201
MDL number:
MFCD00011232

주요 문서

모든 문서 보기
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의

InChI key

VYPSYNLAJGMNEJ-UHFFFAOYSA-N

InChI

1S/O2Si/c1-3-2

SMILES string

O=[Si]=O

agency

NF, Ph. Eur.

product line

EMPROVE® ESSENTIAL

form

fine powder

particle size

17-25 μm (d50)

bp

2230 °C (lit.)

mp

>1600 °C (lit.), 1710 °C

application(s)

pharmaceutical
pharmaceutical
solid formulation
solubility enhancement

storage temp.

2-30°C

Quality Level

500

관련 카테고리

General description

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

Parteck® SLC excipient is an innovative silica drug carrier that enhances drug solubility thanks to its unique surface structure, which can stabilize the amorphous state. This is especially relevant for poor glass forming APIs, which can be difficult to stabilize with other formulation technologies. Parteck® SLC is also emerging as a first-in-class excipient to reduce the risk of unstable polymorphism and particle properties in drug development. In this application, Parteck® SLC can homogenize both properties in a template-based formulation approach, with robust and reliable results.

Features and Benefits

  • Solubility enhancement of APIs
  • Unparalleled stabilization of the amorphous solid state
  • Unique pore structure (6 nm diameter) and a very high surface area (500 m²/g)
  • Perfect fit to stabilize poor glass former molecules
  • Platform approach to manage API particle and polymorph variation
  • No specific equipment/extra capital invest needed to stabilize the amorphous form of APIs
  • High-end application support

Packaging

1200910300 // Wide necked plastic bottle in corrugated box
1200911000 // Wide necked plastic bottle in corrugated box
1200919025 // Standard PE bag in PE square drum

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

저장 등급

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

시험 성적서(COA)

제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

문서

Enhance Solubility With 3D Printing and Mesoporous Silica

Accelerate formulation of APIs with solubility challenges using additive manufacturing (3D printing) with mesoporous silica. Explore this case study!

API Solubility and Dissolution Enhancement Via Formulation

Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.

Improving API Solubility with Mesoporous Silica

Discover how mesoporous silica enhances API solubility, unlocking the full potential of promising drugs with improved bioavailability.

국제 무역 품목 번호

SKUGTIN
1.20091.100004027269967574
1.20091.030004027269573393

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.